Sign In

Antiretroviral Therapy.

HIV Question Bank

Antiretroviral Medications and Initial TherapyQuestion 3/10

Questions in Topic

A 26-year-old cisgender man has a new clinic visit to establish care for HIV and start antiretroviral therapy. About 14 months ago, he started receiving long-acting injectable cabotegravir for HIV preexposure prophylaxis (PrEP). He stopped taking the injectable cabotegravir about 4 months ago and did not have any follow-up visits until a recent visit 3 days ago when he tested positive for HIV. The HIV genotypic drug resistance testing (standard resistance assay and integrase resistance assay) is pending.

According to the Adult and Adolescent ART Guidelines, which one of the following regimens would be recommended as initial therapy for this patient?

Prev  Skip

Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Question Last Updated
October 8th, 2024

Steps to Acquire CE for this Question Bank Topic:

1

Answer

Answer all questions
2

Score 80%+

Answer correctly
3

Claim CE

Choose CNE or CME
4

Give Feedback

Complete survey
5

Print Certificate

Obtain proof of CE

This question requires improvement because:


Comment further on how to improve this question or summary:



Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.